🔗 Permalink

Inventor profile of:

Stefan Müllner

City:

Langenfeld

Country:

Germany

Published Applications:

9

Last publication date:

2017-04-27

Top Assignees for applications by Stefan Müllner

The entities that hold a legal rights for patent applications filed by inventor Müllner Stefan:

PROTAGEN Aktiengesellschaft 4 Dortmund, Germany
Protagen AG 2 Dortmund, Germany
AL-GIAX PHARMACEUTICALS GMBH 1 Erkrath, Germany
Protagen Aktinegesellschaft 1 Dortmund, Germany
SCHEBO BIOTECH AG 1 Giessen, Germany
ALGIAX Pharmaceuticals GmbH 1 , Germany

Recent patent applications by Müllner Stefan

Stefan Müllner from Langenfeld, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2017-04-27

US20170115288A1

Method for the diagnosis of neuromyelitis optica

#2 | 2016-02-25

US20160054318A1

Method for the diagnosis of neuromyelitis optica

#3 | 2014-10-16

US20140309133A1

Method for diagnosis of high-affinity binders and marker sequences

#4 | 2013-11-14

US20130303395A1

MARKER SEQUENCES FOR SYSTEMIC LUPUS ERYTHEMATOSUS AND THE USE THEREOF

#5 | 2013-10-17

US20130274301A1

Human necessities

Use of leflunomide and malononitrilamides

#6 | 2013-01-31

US20130029864A1

BIOMARKERS FOR ALZHEIMER'S DISEASE

#7 | 2010-12-30

US20100331201A1

PROTEIN BIOCHIP FOR THE DIFFERENTIAL SCREENING OF PROTEIN-PROTEIN INTERACTIONS

#8 | 2010-10-07

US20100256230A1

Human necessities

1-BUTANE ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING SAID DERIVATIVES AND THE USE THEREOF

#9 | 2005-03-10

US20050054584A1

Human necessities

Use of sugar phosphates, sugar phosphate analog, amino acids, amino acid analogs for modulating transaminases and/or the association of p36/ malate dehydrogenase

InventorID:

68052 ⎘